NYSE ARCA | ETF
The fund invests primarily in equity securities, principally common and preferred stocks of companies of any market capitalization.
Under normal market conditions, the fund invests at least 80% of its net assets, plus borrowings for investment purposes, in securities of companies principally engaged in the research, development, production, or distribution of products and services related to the health care industry ("health care companies").
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 19.15% |
| ASND | Ascendis Pharma AS | Healthcare | Biotechnology | 16.30% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 6.81% |
| LEGN | Legend Biotech Corp | Healthcare | Biotechnology | 6.03% |
| MASI | Masimo Corporation | Healthcare | Medical Devices | 4.15% |
| PCVX | Vaxcyte Inc | Healthcare | Biotechnology | 3.94% |
| RVMD | Revolution Medicines Inc | Healthcare | Biotechnology | 3.64% |
| SNY | Sanofi ADR | Healthcare | Drug Manufacturers - General | 3.55% |
| UNH | UnitedHealth Group Incorporated | Healthcare | Healthcare Plans | 3.46% |
| HUM | Humana Inc | Healthcare | Healthcare Plans | 2.87% |
| ADMA | ADMA Biologics Inc | Healthcare | Biotechnology | 2.85% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 2.77% |
| HQY | HealthEquity Inc | Healthcare | Health Information Services | 2.42% |
| 6XC | SOLENO THERAPEUT. DL-001 | Healthcare | Biotechnology | 2.39% |
| CVS | CVS Health Corp | Healthcare | Healthcare Plans | 2.32% |
| DHR | Danaher Corporation | Healthcare | Diagnostics & Research | 2.29% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 2.25% |
| MLTX_old | Multex Com Inc | Other | Other | 2.25% |
| AAVXF | ABIVAX Société Anonyme | Healthcare | Biotechnology | 2.14% |
| BSX | Boston Scientific Corp | Healthcare | Medical Devices | 1.88% |